Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Akt
    (1)
  • Apoptosis
    (1)
  • Beta Amyloid
    (1)
  • Casein Kinase
    (1)
  • Wnt/beta-catenin
    (1)
  • Others
    (1)
TargetMol | Tags By Natures
  • Haematoxylum
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

hematoxylin

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
Hematoxylin
Natural Black 1, Hydroxybrazilin, Haematoxylin
T1686517-28-2
Hematoxylin (Natural Black 1) is a dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
Hematein
Hydroxybrasilein
T15469475-25-2
Hematein inhibits Akt/PKB Ser129 phosphorylation, the Wnt/TCF pathway, and increases apoptosis in lung cancer cells. Hematein is an oxidation product of hematoxylin acted as a dye and it also is an allosteric casein kinase II inhibitor (IC50: 0.74 μM).
  • $29
In Stock
Size
QTY
DW532
T710821267949-42-7
DW532 is one of simplified analogues of hematoxylin that has shown broad-spectrum inhibition on tyrosine kinases and in vitro anti-cancer activities. DW532 inhibited EGFR and VEGFR2 in vitro kinase activity (the IC50 values were 4.9 and 5.5 μmol/L, respectively), and suppressed their downstream signaling. DW532 dose-dependently inhibited tubulin polymerization via direct binding to tubulin, thus disrupting the mitotic spindle assembly and leading to abnormal cell division. In a panel of human cancer cells, DW532 (1 and 10 μmol/L) induced G2/M phase arrest and cell apoptosis, which subsequently resulted in cytotoxicity. Knockdown of BubR1 or Mps1, the two core proteins of the spindle assembly checkpoint dramatically decreased DW532-induced cell cycle arrest in MDA-MB-468 cells. Moreover, treatment with DW532 potently and dose-dependently suppressed angiogenesis in vitro and in vivo. ( Acta Pharmacol Sin. 2014 Jul;35(7):916-28.)
  • $1,520
6-8 weeks
Size
QTY